Background Following the first investigational study on the use of extracorporeal
photopheresis for the treatment of cutaneous T‐cell lymphoma published in 1983, this …

Background Following the first investigational study on the use of extracorporeal
photopheresis for the treatment of cutaneous T‐cell lymphoma published in 1983, this …

Background After the first investigational study on the use of extracorporeal photopheresis
for the treatment of cutaneous T‐cell lymphoma was published in 1983 with its subsequent …

This synopsis reviews recent developments in dermatological phototherapy. UVA1
phototherapy (340-400 nm) is effective in the treatment of inflammatory skin diseases such …

Extracorporeal photopheresis (ECP) has been used for over 30 years in the treatment of
erythrodermic cutaneous T‐cell lymphoma (CTCL) and over 20 years for chronic graft …

Extracorporeal photopheresis (ECP) is a technique that was developed> 20 years ago to
treat erythrodermic cutaneous T‐cell lymphoma (CTCL). The technique involves removal of …

Extracorporeal photopheresis (ECP) has been used for over 35 years in the treatment of
erythrodermic cutaneous T‐cell lymphoma (CTCL) and over 20 years for chronic and acute …

Extracorporeal photopheresis (ECP) is a therapeutic procedure in which leukapheresed
peripheral blood mononuclear cells are exposed to ultraviolet A in the presence of the …

Extracorporeal photophoresis (ECP), a therapeutic modality that has been under
investigation for some years, is based on separation of a leucocyte/lymphocyte-enriched cell …

Purpose Extracorporeal photopheresis (ECP) is effective for treating cutaneous T‐cell
lymphoma. In 1987, a pivotal trial showed 81% overall response rate (ORR) using outdated …